Board Moves.

ACADIA Pharmaceuticals (NASDAQ: ACAD)

Catherine Adams named Chief Executive Officer and she is appointed to the Board of DIrectors. Ms. Adams is the former Senior Vice President and General Manager, U.S. at Bristol Myers Squibb.

Baxter Int’l (NYSE: BAX)

Appoints Jay Craig to the Board of Directors. Mr. Craig is the former Chair of the Board and CEO at Meritor.

BeiGene (NASDAQ: BGNE)

Appoints Shalini Sharp to the Board of Directors. Ms. Sharp is the former Chief Financial Officer at Ultragenyx .

Biogen (NASDAQ: BIIB)

Appoints Lloyd Minor and Menelas Pangalos to the Board of DIrectors. Mr. Minor is the Dean at Stanford University School of Medicine and Mr. Pangalos is the former Executive Vice President, BioPharmaceuticals R&D at AstraZeneca.

Cassava Sciences (NASDAQ: SAVA)

Richard Barry named CEO and he continues on the Board of Directors and as Executive Chair of the Board. Mr. Barry is a former Partner at San Diego Padres.

Dianthus Therapeutics (NASDAQ: DNTH)

Appoints Steven Romano to the Board of Directors. Mr. Romano is the Chief R&D Officer at Silence Therapeutics.

Kura Oncology (NASDAQ: KURA)

Appoints Michael Vasconcelles to the Board of Directors. Mr. Vasconcelles is a Senior Advisor at Frazier Healthcare Partners.

Kyverna Therapeutics (NASDAQ: KYTX)

Warner Biddle named Chief Executive Officer and he is appointed to the Board of Directors. Mr. Biddle is the former Global Head of Commercial at Kite Pharma.

Lantheus (NASDAQ: LNTH)

Appoints Julie Eastland to the Board of Directors. Ms. Eastland is the former Chief Executive Officer at Harpoon Therapeutics.

Nu Skin Enterprises (NYSE: NUS)

Appoints Mark Zorko to the Board of Directors. Mr. Zorko is the Principal and Founder at Brentwood Advisory Group.

OraSure Technologies (NASDAQ: OSUR)

Appoints John Kenny to the Board of Directors. Mr. Kenny is the former Chief Executive Officer at Meridian Bioscience.

Rocket Pharmaceuticals (NASDAQ: RCKT)

Appoints Mikael Dolsten to the Board of Directors. Mr. Dolsten is the Chief Scientific Officer & President at Pfizer.

Sarepta Therapeutics (NASDAQ: SRPT)

Appoints Deirdre Connelly to the Board of Directors. Ms. Connelly is a former President at GlaxoSmithKline.

‍

‍

Aurinia Pharmaceuticals (NASDAQ: AUPH)

Daniel Billen, Hector MacKay-Dunn, and Brinda Balakrishnan resign from the Board of Directors. Mr. Billen is the former Vice President of Global Commercial Initiatives at Amgen, Mr. MacKay-Dunn is a Partner at Farris and Ms. Balakrishnan is the Chief Corporate Strategy and Business Development Officer at BioMarin Pharmaceuticals.

Cardinal Health (NYSE: CAH)

Steven Barg and Sujatha Chandrasekaran leave the Board of Directors. Mr. Barg is the Principal at Elliott Management and Ms. Chandrasekaran is the former Chief Digital & Information Officer at CommonSpirit Health.

Centene (NYSE: CNC)

Lori Robinson to leave the Board of Directors. Ms. Robinson is a former General in the U.S. Air Force.

Johnson & Johnson (NYSE: JNJ)

D. Scott Davis retires from the Board of Directors. Mr. Davis is the former Chair of the Board and Chief Executive Officer at United Parcel Service.

Lifecore Biomedical (NASDAQ: LFCR)

Ray Diradoorian and Jeffrey Edwards to leave the Board of Directors. Mr. Diradoorian is the former EVP of Global Technical Operations at Allergan and Mr. Edwards is the former Chief Financial Officer at Allergan.

Option Care Health (NASDAQ: OPCH)

John Arlotta resigns from the Board of Directors. Mr. Arlotta is the Chair of the Board and Chief Executive Officer at eviCore Healthcare.

PepGen (NASDAQ: PEPG)

Christopher Ashton resigns from the Board of Directors. Mr. Ashton is the Chief Executive Officer at Achilles Therapeutics.

Protagonist Therapeutics (NASDAQ: PTGX)

Daniel Swisher resigns from the Board of Directors. Mr. Swisher is the former President and Chief Operating Officer at Jazz Pharmaceuticals.

Rigel Pharmaceuticals (NASDAQ: RIGL)

Brian Kotzin resigns from the Board of Directors. Mr. Kotzin is the former Chief Medical Officer at Nektar Therapeutics.

Sotera Health (NASDAQ: SHC)

David Donnini resigns from the Board of Directors. Mr. Donnini is the Managing Director at GTCR.

UroGen Pharma (NASDAQ: URGN)

Fred Cohen resigns from the Board of Directors. Mr. Cohen is a Senior Advisor at TPG Capital.